Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18637707 | METHODS FOR QUANTIFYING FRATAXIN ACTIVITY | April 2024 | May 2025 | Allow | 13 | 1 | 0 | Yes | No |
| 18627241 | SPORE-BASED PROBIOTIC SUPPLEMENTATION IN DOGS AND CONTROL OF ENDOTOXEMIA | April 2024 | April 2025 | Allow | 12 | 1 | 0 | No | No |
| 18594570 | EDIBLE PLANT PARTS ENRICHED WITH PROBIOTIC BACTERIA | March 2024 | June 2025 | Allow | 15 | 1 | 0 | Yes | No |
| 18406008 | TREATMENT OF VON WILLEBRAND DISEASE | January 2024 | January 2025 | Allow | 12 | 1 | 0 | No | No |
| 18492533 | NEUROTOXIN COMPOSITIONS FOR USE IN TREATING HEADACHE | October 2023 | January 2025 | Abandon | 15 | 1 | 0 | No | No |
| 18490629 | PROBIOTIC COMPOSITION | October 2023 | April 2025 | Allow | 18 | 2 | 0 | No | No |
| 18351961 | NOVEL BACTERIOPHAGE THAT LYSES ACINETOBACTER GENUS BACTERIA HAVING RESISTANCE TO ANTIBIOTICS | July 2023 | September 2024 | Abandon | 14 | 0 | 1 | No | No |
| 18270925 | COMPOSITION COMPRISING THREE LACTOBACILLUS SP. STRAINS, AND USE THEREOF | July 2023 | March 2025 | Allow | 20 | 3 | 0 | Yes | No |
| 18336973 | APPLICATION OF MEDICAL CELL CMU-PB-7 IN PREPARATION OF BLOOD LIPID-LOWERING DRUGS | June 2023 | February 2024 | Allow | 8 | 2 | 0 | No | No |
| 18317309 | DYSOSMOBACTER, A NOVEL BACTERIAL GENUS OF THE GASTROINSTESTINAL MICROBIOTA AND USES THEREOF | May 2023 | April 2025 | Allow | 23 | 2 | 1 | Yes | No |
| 18314864 | Chimeric endolysin polypeptide, cluster 3b | May 2023 | September 2024 | Allow | 16 | 2 | 1 | Yes | No |
| 18301188 | THERAPEUTIC BACTERIOPHAGE COMPOSITIONS FOR TREATING STAPHYLOCOCCUS INFECTION | April 2023 | November 2024 | Allow | 19 | 1 | 1 | No | No |
| 18133168 | PHARMACEUTICAL COMPOSITION, PACKAGE AND METHOD FOR PRODUCING THE SAME | April 2023 | December 2024 | Allow | 20 | 2 | 0 | Yes | No |
| 18053245 | BACTERIOPHAGE COMPOSITIONS AND METHODS FOR TREATMENT OF BACTERIAL INFECTIONS | November 2022 | May 2024 | Abandon | 18 | 1 | 1 | No | No |
| 18049770 | NANO-VESICLES DERIVED FROM GENUS SPHINGOMONAS BACTERIA AND USE THEREOF | October 2022 | December 2023 | Allow | 13 | 1 | 0 | Yes | No |
| 17950886 | COMPOSITION FOR SUPPRESSING FAT ACCUMULATION | September 2022 | September 2024 | Abandon | 24 | 2 | 0 | No | No |
| 17818834 | MICROBIAL COMPOSITIONS AND METHODS OF USE FOR CANINE ENTEROPATHY AND DYSBIOSIS | August 2022 | June 2024 | Allow | 23 | 3 | 1 | Yes | No |
| 17813190 | 3D PRINTED, FREEZE-DRIED HYDROGELS AND METHODS OF MAKING AND USING THE SAME | July 2022 | May 2025 | Allow | 34 | 4 | 1 | Yes | No |
| 17770042 | COMPOSITIONS FOR GUT HEALTH | April 2022 | November 2024 | Allow | 31 | 1 | 0 | Yes | No |
| 17712951 | METHODS AND PROCESSES FOR TREATING THE GLABELLA | April 2022 | April 2025 | Abandon | 36 | 1 | 0 | No | No |
| 17604972 | MICROBIOTA TRANSFER THERAPY FOR PITT HOPKINS SYNDROME | October 2021 | December 2024 | Allow | 38 | 1 | 1 | Yes | No |
| 17604960 | LACTOBACILLUS RHAMNOSUS LRH05 ISOLATE, AND COMPOSITION INCLUDING THE SAME AND USE THEREOF | October 2021 | November 2024 | Allow | 37 | 1 | 0 | No | No |
| 17602131 | METHODS OF INCREASING THE GERMINATION RATE OF FUNGAL SPORES | October 2021 | April 2025 | Abandon | 42 | 1 | 0 | No | No |
| 17490734 | USE OF FAECALIBACTERIUM PRAUSNITZII IN PREPARATION OF MEDICINE FOR TREATING PATHOLOGICAL VENTRICULAR REMODELING AND/OR HEART FAILURE FOLLOWING MYOCARDIAL INFARCTION | September 2021 | March 2023 | Allow | 17 | 1 | 0 | Yes | No |
| 17478017 | COMPOSITIONS AND METHODS FOR CONTROLLING MYCOTOXIN PRODUCTION | September 2021 | April 2024 | Abandon | 31 | 1 | 0 | No | No |
| 17386917 | BIOLUMINESCENT SENSOR FOR ISOTHIOCYANATES | July 2021 | June 2024 | Allow | 34 | 1 | 1 | Yes | No |
| 17421965 | CHLAMYDOMONAS MUTANT AND USE THEREOF | July 2021 | March 2025 | Allow | 44 | 1 | 1 | Yes | No |
| 17354531 | NOVEL KIMCHI-DERIVED LACTOBACILLUS FERMENTUM STRAIN WITH EXCELLENT ANTI-INFLAMMATORY ACTIVITY AND COMPOSITION INCLUDING SAME FOR PREVENTION AND TREATMENT OF INFLAMMATORY DISEASES | June 2021 | January 2023 | Abandon | 19 | 0 | 1 | No | No |
| 17413306 | COMPOSITION FOR THE PREVENTION AND TREATMENT OF SKIN DISEASES | June 2021 | October 2024 | Abandon | 40 | 0 | 1 | No | No |
| 17344372 | SWINE ORIGIN PROBIOTICS THAT PROMOTE HEALTH AND GROWTH PERFORMANCE IN PIGS | June 2021 | October 2024 | Allow | 40 | 4 | 0 | Yes | Yes |
| 17298386 | BOTULINUM TOXIN-STABILIZING LIQUID COMPOSITION | May 2021 | August 2024 | Abandon | 39 | 1 | 0 | No | No |
| 17291313 | COMBINATION THERAPIES OF MICROORGANISMS AND IMMUNE MODULATORS FOR USE IN TREATING CANCER | May 2021 | August 2024 | Abandon | 39 | 0 | 1 | No | No |
| 17246977 | COMPOSITION FOR PROMOTING DEFECATION AND USE THEREFOR | May 2021 | January 2023 | Allow | 21 | 1 | 0 | Yes | No |
| 17246124 | ADMINISTRATION OF SEGMENTED FILAMENTOUS BACTERIA WITH A HUMIC SUBSTANCE | April 2021 | March 2024 | Abandon | 34 | 2 | 1 | No | No |
| 17281926 | BACTERIAL STRAINS OF THE LACTOBACILLUS PARACASEI SPECIES FOR USE, ORAL OR TOPICAL, IN THE TREATMENT OF DISORDERS OF THE FEMALE UROGENITAL TRACT | March 2021 | October 2022 | Abandon | 18 | 2 | 1 | Yes | No |
| 17275839 | ANIMAL FEED COMPOSITIONS AND USES THEREOF | March 2021 | December 2023 | Abandon | 34 | 0 | 1 | No | No |
| 17185256 | MICROBIAL FEED SUPPLEMENT COMPOSITION AND METHOD | February 2021 | February 2025 | Allow | 48 | 5 | 1 | Yes | No |
| 17269135 | METHODS AND COMPOSITIONS FOR HONEY BEE HEALTH | February 2021 | July 2024 | Allow | 41 | 2 | 1 | Yes | No |
| 17166490 | TREATMENT OF VON WILLEBRAND DISEASE | February 2021 | October 2023 | Allow | 33 | 2 | 0 | Yes | No |
| 17166015 | COMPOSITIONS FOR GUT HEALTH | February 2021 | November 2024 | Allow | 45 | 1 | 1 | Yes | No |
| 17265169 | NOVEL NICOTINE DEGRADING ENZYME VARIANTS | February 2021 | February 2025 | Allow | 48 | 2 | 1 | Yes | No |
| 17153761 | NUCLEIC ACID MODIFICATION WITH TOOLS FROM OXYTRICHA | January 2021 | June 2025 | Abandon | 53 | 2 | 1 | No | No |
| 17146674 | TISSUE STAINING COMPOSITION AND TISSUE STAINING METHOD USING SAME | January 2021 | November 2023 | Allow | 34 | 2 | 1 | Yes | No |
| 17142601 | QUANTITATIVE CHARACTERIZATION OF ALGAL BIOMASS BIOMOLECULES | January 2021 | October 2024 | Allow | 45 | 3 | 1 | Yes | No |
| 17258256 | DYSOSMOBACTER, A NOVEL BACTERIAL GENUS OF THE GASTROINTESTINAL MICROBIOTA AND USES THEREOF | January 2021 | February 2023 | Allow | 25 | 2 | 1 | Yes | No |
| 17141692 | BACTERIOPHAGE LYSIN AND ANTIBIOTIC COMBINATIONS AGAINST GRAM POSITIVE BACTERIA | January 2021 | July 2024 | Abandon | 43 | 1 | 0 | No | No |
| 17133660 | HYBRID HYDROGEL CARRIER FOR HIGH-SALINITY WASTEWATER TREATMENT AND PREPARATION METHOD THEREOF | December 2020 | May 2025 | Abandon | 52 | 4 | 1 | Yes | No |
| 17132270 | Method for Enzymatic Sulfurylation of Alcohols and Amines Using Bacterium of the Family Enterobacteriaceae | December 2020 | June 2024 | Allow | 41 | 1 | 0 | Yes | No |
| 17252998 | LYSIN CF-301 RESENSITIZES METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUA (MRSA) TO PENICILLIN DERIVATIVES AND FIRST GENERATION CEPHALOSPORINS | December 2020 | June 2024 | Abandon | 42 | 1 | 0 | No | No |
| 17105149 | METHODS FOR QUANTIFYING FRATAXIN ACTIVITY | November 2020 | February 2024 | Allow | 39 | 1 | 1 | Yes | No |
| 16951050 | METHODS AND COMPOSITIONS FOR DETECTING BETA-HYDROXYBUTYRATE IN BIOLOGICAL FLUIDS | November 2020 | October 2023 | Abandon | 34 | 1 | 1 | No | No |
| 16950323 | Use of Lactobacillus Plantarum S58 in Preparation of Product for Alleviating Spicy Food-Induced Damage to Digestive System | November 2020 | December 2022 | Abandon | 25 | 2 | 0 | No | No |
| 17085350 | NOVEL BACTERIOPHAGE THAT LYSES ACINETOBACTER GENUS BACTERIA HAVING RESISTANCE TO ANTIBIOTICS | October 2020 | August 2023 | Abandon | 34 | 1 | 1 | No | No |
| 17050982 | MICROBIALS FOR FEED | October 2020 | November 2023 | Allow | 37 | 2 | 1 | Yes | No |
| 17078376 | RECOMBINANT L-ASPARAGINASE | October 2020 | July 2024 | Allow | 45 | 4 | 0 | Yes | No |
| 17048930 | COMPOSITION FOR TYPE IV ALLERGY | October 2020 | December 2022 | Abandon | 26 | 1 | 0 | No | No |
| 17048924 | COMPOSITION FOR SUPPRESSING FAT ACCUMULATION | October 2020 | April 2023 | Abandon | 30 | 2 | 0 | No | No |
| 17071956 | MICRO-ORGANISMAL PRODUCT AND METHOD FOR TREATING SICKLE CELL DISEASE | October 2020 | January 2023 | Abandon | 27 | 1 | 0 | No | No |
| 17046103 | EDIBLE PLANT PARTS ENRICHED WITH PROBIOTIC BACTERIA | October 2020 | December 2023 | Allow | 39 | 3 | 1 | Yes | No |
| 17060175 | COMPOSITIONS AND METHODS FOR INHIBITING THE PROLIFERATION OF PATHOGENIC ESCHERICHIA COLI | October 2020 | February 2023 | Allow | 28 | 2 | 1 | Yes | No |
| 17043545 | COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASES | September 2020 | February 2024 | Abandon | 40 | 2 | 1 | No | No |
| 15733682 | TREATMENT OF A CANCER BY MICROBIOME MODULATION | September 2020 | June 2024 | Abandon | 45 | 2 | 1 | No | No |
| 17033195 | BACTERIOPHAGE LYSIN AND ANTIBIOTIC COMBINATIONS AGAINST GRAM POSITIVE BACTERIA | September 2020 | July 2024 | Abandon | 46 | 1 | 1 | No | No |
| 17040676 | Composition for Inactivating Smell Component | September 2020 | March 2024 | Abandon | 42 | 0 | 1 | No | No |
| 17023097 | SPORE-BASED PROBIOTIC SUPPLEMENTATION IN DOGS AND CONTROL OF ENDOTOXEMIA | September 2020 | December 2022 | Abandon | 27 | 2 | 1 | Yes | No |
| 17006685 | NEUROTOXIN COMPOSITIONS FOR USE IN TREATING HEADACHE | August 2020 | July 2023 | Allow | 35 | 2 | 0 | Yes | No |
| 17006430 | COMPOSITIONS COMPRISING BACTERIAL SPECIES AND METHODS RELATED THERETO | August 2020 | February 2024 | Allow | 42 | 3 | 1 | Yes | No |
| 16975546 | PHARMACEUTICAL COMPOSITION, PACKAGE AND METHOD FOR PRODUCING THE SAME | August 2020 | January 2023 | Allow | 28 | 2 | 0 | Yes | No |
| 16987061 | COMPOSITION, PRODUCTION METHOD FOR PRODUCING THE SAME, AND METHOD OF PREVENTING CAKING | August 2020 | October 2023 | Abandon | 38 | 3 | 0 | Yes | No |
| 16965471 | POSTBIOTIC-BASED COMPOSITION FOR THE MODULATION OF IMMUNE SYSTEM ACTIVATION AND PROTECTION OF MUCOSAL BARRIERS | July 2020 | August 2024 | Allow | 48 | 3 | 1 | Yes | No |
| 16939170 | COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE | July 2020 | June 2025 | Abandon | 58 | 4 | 1 | No | Yes |
| 16937248 | USE OF THE TREATMENT OR IMPROVEMENT OF SLEEP DISORDERS BY LACTOBACILLUS BREVIS PROGA28 AND/OR ITS METABOLITES | July 2020 | August 2022 | Allow | 25 | 2 | 0 | Yes | No |
| 16962976 | LACTOBACILLUS PLANTARUM KBL396 STRAIN AND USE THEREOF | July 2020 | November 2022 | Allow | 28 | 2 | 0 | Yes | No |
| 16960318 | PROBIOTIC BACTERIA FOR FISH | July 2020 | July 2025 | Allow | 60 | 4 | 1 | Yes | No |
| 16959666 | THERAPEUTIC BACTERIOPHAGE COMPOSITIONS FOR TREATING STAPHYLOCOCCUS INFECTION | July 2020 | January 2023 | Allow | 30 | 1 | 0 | Yes | No |
| 16954383 | ANIMAL FEED COMPOSITIONS AND USES THEREOF | June 2020 | June 2023 | Abandon | 36 | 1 | 1 | No | No |
| 16771075 | COMPOSITIONS AND METHODS FOR SUPPRESSING PATHOGENIC ORGANISMS | June 2020 | March 2024 | Allow | 45 | 3 | 1 | Yes | No |
| 16770432 | BACTERIOPHAGE TREATMENT FOR ACNE AND BIOFILMS | June 2020 | January 2024 | Abandon | 44 | 2 | 1 | No | No |
| 16766389 | A COMPOSITION COMPRISING A COHORT OF BACTERIA | May 2020 | April 2024 | Abandon | 47 | 3 | 0 | No | No |
| 16762260 | COMPOSITION FOR IMPROVING THE WELL-BEING OF ANIMALS | May 2020 | November 2022 | Abandon | 30 | 2 | 0 | No | No |
| 16760590 | DIAGNOSTIC AND THERAPEUTIC METHODS FOR TYPE 2 DIABETES | April 2020 | June 2022 | Abandon | 25 | 0 | 1 | No | No |
| 16759201 | FORMULATIONS COMPRISING GLUCOCEREBROSIDASE AND ISOFAGOMINE | April 2020 | November 2023 | Abandon | 43 | 3 | 1 | No | No |
| 16755801 | PROBIOTIC COMPOSITION | April 2020 | July 2023 | Allow | 39 | 3 | 1 | Yes | No |
| 16840334 | COMPOSITIONS AND METHODS FOR INHIBITING THE PROLIFERATION OF PATHOGENIC ESCHERICHIA COLI | April 2020 | November 2022 | Allow | 32 | 2 | 1 | Yes | No |
| 16753388 | BOTULINUM NEUROTOXIN A SUBTYPE 6 AND PHARMACOLOGICAL METHODS OF USE | April 2020 | April 2024 | Abandon | 48 | 3 | 1 | Yes | No |
| 16652608 | Pasture Treatments for Enhanced Carbon Sequestration and Reduction in Livestock-Produced Greenhouse Gas Emissions | March 2020 | July 2023 | Allow | 39 | 2 | 1 | Yes | No |
| 16816903 | METHOD FOR TREATING AND/OR PREVENTING COCCIDIOSIS | March 2020 | August 2022 | Abandon | 29 | 2 | 0 | No | No |
| 16639378 | NOVEL METHODS FOR THE TARGETED INTRODUCTION OF VIRUSES INTO CELLS AND TISSUES | February 2020 | July 2023 | Abandon | 41 | 2 | 0 | No | No |
| 16788990 | COMPOSITION FOR COMPETITIVE INHIBITION OF PATHOGENS AND RESTORATION OF MICROBIAL ECOLOGICAL BALANCE | February 2020 | May 2024 | Allow | 51 | 4 | 1 | Yes | No |
| 16788257 | Combined Multistage Microbial Preparations and Method of Their Application | February 2020 | August 2022 | Abandon | 30 | 1 | 1 | No | No |
| 16779776 | METHOD FOR DETECTING DIFFERENT PROPERTIES IN A MICROORGANISM POPULATION BY OPTICALLY INDUCED DIELECTROPHORETIC FORCE | February 2020 | November 2022 | Abandon | 33 | 1 | 0 | No | No |
| 16750148 | SAMPLE PROTECTION METHOD | January 2020 | March 2023 | Allow | 38 | 1 | 0 | Yes | No |
| 16631491 | NANO-VESICLES DERIVED FROM GENUS SPHINGOMONAS BACTERIA AND USE THEREOF | January 2020 | August 2022 | Allow | 31 | 1 | 1 | No | No |
| 16677815 | METHOD OF PRODUCING HIGH FUCOXANTHIN-CONTAINING ALGA | November 2019 | January 2023 | Abandon | 38 | 1 | 1 | No | No |
| 16611877 | VIBRIO PARAHAEMOLYTICUS BACTERIOPHAGE VIB-PAP-7 AND USE OF SAME FOR INHIBITING VIBRIO PARAHAEMOLYTICUS BACTERIA PROLIFERATION | November 2019 | March 2023 | Allow | 41 | 3 | 0 | Yes | No |
| 16607921 | Methods and Compositions for Storing Bacteria | October 2019 | January 2023 | Abandon | 39 | 2 | 1 | No | No |
| 16597509 | TOBACCO MOSAIC VIRUS DELIVERY OF MITOXANTRONE FOR CANCER THERAPY | October 2019 | June 2024 | Abandon | 57 | 5 | 0 | No | No |
| 16500558 | MICROBIAL INSECTICIDE FOR CONTROL OF MULBERRY THRIPS | October 2019 | December 2024 | Abandon | 60 | 7 | 0 | Yes | No |
| 16582053 | LUNG PROTEASE NANOSENSORS AND USES THEREOF | September 2019 | August 2024 | Allow | 58 | 2 | 1 | Yes | No |
| 16487628 | METHODS FOR IMPROVING FILTERABILITY OF POLYSACCHARIDE-PROTEIN CONJUGATE REACTIONS | August 2019 | May 2024 | Abandon | 56 | 3 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner CURRENS, GRANT CARSON.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 0.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner CURRENS, GRANT CARSON works in Art Unit 1651 and has examined 109 patent applications in our dataset. With an allowance rate of 52.3%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 39 months.
Examiner CURRENS, GRANT CARSON's allowance rate of 52.3% places them in the 9% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by CURRENS, GRANT CARSON receive 1.93 office actions before reaching final disposition. This places the examiner in the 62% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by CURRENS, GRANT CARSON is 39 months. This places the examiner in the 9% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +76.5% benefit to allowance rate for applications examined by CURRENS, GRANT CARSON. This interview benefit is in the 99% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 28.6% of applications are subsequently allowed. This success rate is in the 42% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 48.5% of cases where such amendments are filed. This entry rate is in the 68% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 85% percentile among all examiners. Of these withdrawals, 100.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 58.8% are granted (fully or in part). This grant rate is in the 75% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 2% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 3.5% of allowed cases (in the 74% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.